Listen To What Our Students & Faculty Have To Say
Message from the Chair, Ann Dozier, Ph.D.
Welcome to the Department of Public Health Sciences at the University of Rochester Medical Center. We are a welcoming, dynamic group dedicated to the improvement of health and health care among diverse populations through research, learning, and community partnerships. Our faculty members engaged in research activities across the lifespan from maternal-child health to long-term care. Our scientific inquiry uses a range of rigorous methodologies from high powered analytics to mixed methods. Our educational offerings provide multiple alternatives. These include PhD programs in Epidemiology and Health Services Research, Master's programs in Public Health, Epidemiology, Clinical Investigation, and Health Services Research, and 6 Advanced Certificates in Epidemiology, Health Services Research, Biomedical Informatics, Public Health, and Regulatory Science. I invite you to explore our website to learn more about who we are and the services we offer.
View all news »
Study will Explore Air Pollution’s Impact on the Developing Fetus
The new $2.49 million National Institute of Environmental Health Sciences-sponsored study will be led by David Rich, Sc.D., M.P.H., an associate professor in the University of Rochester Medical Center (URMC) Department of Public Health Sciences, and Jim Zhang, Ph.D., with Duke University.
AnnaLynn Williams, a doctoral candidate in Epidemiology, received a F99/K00 Predoctoral to Postdoctoral Transition Award from the National Cancer Institute.
Ms. Williams will examine the potential impact of cancer treatment and inflammation on cancer-related cognitive impairment and other psychosocial symptoms. This award will provide a pre- and post-doctoral translational and multidisciplinary research training experience for Ms. Williams, who intends to pursue a career in cancer survivorship research that addresses questions of direct clinical relevance using an innovative research paradigm that combines public health, clinical, and basic science approaches. This is of emerging importance as the number of cancer survivors is expected to reach 18 million by 2022. Ms. Williams primary co-mentors are Edwin van Wijngaarden, Ph.D. and Michelle Janelsins, Ph.D. (Divisions of Epidemiology and Cancer Control and Survivorship respectively); in addition she is mentored by Christopher Seplaki, Ph.D. (Division of Epidemiology) and Clive Zent, M.D. (Dept. of Hematology/Oncology).
- Rochester will create a new coordinating center for the Clinical and Translational Science Awards Program with funding from the National Institutes of Health. The new Center for Leading Innovation and Collaboration will coordinate over 50 of the nation’s top biomedical research institutes, including the University’s own Clinical and Translational Science Institute. Read more…